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Abstract
 
B cell receptor (BCR) signaling is mediated through immunoglobulin (Ig)
 
 
 
 and Ig
 
 
 
 a membrane-
bound heterodimer. Ig
 
 
 
 and Ig
 
 
 
 are redundant in their ability to support early B cell development,
but their roles in mature B cells have not been defined. To examine the function of Ig
 
 
 
–Ig
 
 
 
 in
mature B cells in vivo we exchanged the cytoplasmic domain of Ig
 
 
 
 for the cytoplasmic domain
 
of Ig
 
 
 
 by gene targeting (Ig
 
 
 
c
 
→
 
 
 
c
 
 mice). Ig
 
 
 
c
 
→
 
 
 
c
 
 B cells had lower levels of surface IgM and
higher levels of BCR internalization than wild-type B cells. The mutant B cells were able to
complete all stages of development and were long lived, but failed to differentiate into B1a
cells. In addition, Ig
 
 
 
c
 
→
 
 
 
c
 
 B cells showed decreased proliferative and Ca
 
2
 
 
 
 responses to BCR
stimulation in vitro, and were anergic to T-independent and -dependent antigens in vivo.
Key words: B cell receptor • immunoglobulin • signal transduction • anergy • B cell development
 
Introduction
 
Signaling by membrane Ig (mIg) regulates antigen-inde-
pendent B cell development, antigen-dependent adaptive
immune responses, and B cell survival (1, 2). Signals are
transmitted from mIg to the cytoplasm through Ig
 
 
 
 and
Ig
 
 
 
, which form a disulfide-linked membrane-bound het-
erodimer that is noncovalently associated with mIg through
polar residues in the plane of the cell membrane (3–7). Ig
 
 
 
and Ig
 
 
 
 contain tyrosine residues that are imbedded in
immunoreceptor tyrosine-based activation motifs (ITAMs)
that are essential for B cell receptor (BCR) signaling (6–11).
Upon BCR cross-linking these tyrosine residues recruit and
serve as substrates for src and syk family kinases (12–21).
Deletion of src kinases blk, fyn, and lyn results in a severe,
but incomplete, block at the preB cell stage of development
and the combination of syk and zap70 mutation abrogates
B cell development (15, 22–24).
Although the cytoplasmic domains of both Ig
 
 
 
 and Ig
 
 
 
contain essential ITAMs they are otherwise nonhomologous
and they display different signaling properties in transfected
cell lines (9, 16). Only Ig
 
 
 
 has non-ITAM tyrosines that
bind SLP-65, which in turn recruit Grb2, Nck, Vav, Btk,
and PLC-
 
 
 
2 (20, 25–27). These differences, and the obser-
vation that Ig
 
 
 
 and Ig
 
 
 
 cytoplasmic domains bind to distinct
sets of kinases in cytoplasmic extracts, led to the suggestion
that the two signal transducers have different functions in
vivo (6, 7, 9, 11, 16, 28–30). However, studies in transgenic
and gene-targeted mice showed that Ig
 
 
 
 and Ig
 
 
 
 have nearly
equivalent function for all aspects of early B cell develop-
ment (31–35). Either the Ig
 
 
 
 or the Ig
 
 
 
 cytoplasmic domain
is sufficient to induce early B cell development in transgenic
mice by a mechanism that requires ITAM tyrosine phos-
phorylation (32, 33). In addition, selective deletion of Ig
 
 
 
 or
Ig
 
 
 
 cytoplasmic domains by gene targeting (Ig
 
  
 
C and
Ig
 
  
 
C mice, respectively) results in a block in B cell devel-
opment that is more severe in early B cells in Ig
 
  
 
C than in
Ig
 
  
 
C mice (34, 35). Both Ig
 
  
 
C and Ig
 
  
 
C mice display
a near absence of mature B cells in the periphery (34–36).
To determine whether the cytoplasmic domains of Ig
 
 
 
and Ig
 
 
 
 have distinct signaling activities in mature B cells
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oxyuridine; CFDA,SE, 5-carboxyfluorescein diacetate succinimidyl ester;
CGG, chicken gamma globulin; IP, immunoprecipitation; ITAM, immu-
noreceptor tyrosine activation motif; MIg, membrane Ig; NP, nitrophenol. 
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in vivo we replaced the cytoplasmic tail of Ig
 
 
 
 with the cy-
toplasmic domain of the Ig
 
 
 
 and produced a BCR that
contains a homodimer of Ig
 
 
 
 tails instead of the normal
physiologic heterodimer of Ig
 
 
 
 and Ig
 
 
 
. Here we report
that all B cell subsets, with the exception of B1 cells, devel-
oped normally in Ig
 
 
 
c
 
→
 
 
 
c
 
 mice, but mature B cells had re-
duced cell surface BCR and were anergic.
 
Materials and Methods
 
Mice.
 
 Ig
 
 
 
c
 
→
 
 
 
c
 
 mice carry an Ig
 
 
 
 gene in which the cyto-
plasmic tail of Ig
 
 
 
 from positions 183–228 was replaced with the
cytoplasmic tail of Ig
 
 
 
 from positions 161–220 by gene targeting
in 129/Sv embryonic stem cells. A cDNA containing the coding
sequence for Ig
 
 
 
 from positions 161–220 followed by a stop
codon, TGA, was inserted after amino acid position 182 in the
Ig
 
 
 
 gene. A unique HindIII site was placed into the targeting
vector as indicated (see Fig. 1 A). The long arm of the targeting
construct was 16 kb, the short arm was 6 kb, a LoxP-flanked
neomycin-resistance gene was used for positive selection, and a
diphtheria toxin gene for negative selection (37). Homologous
integrants were confirmed by Southern blotting after digestion
with HindIII. The genomic fragment used as a probe for South-
ern blotting was generated by PCR with the primers 5
 
 
 
 GGA
TTC GAA TGG TGA ATG TTG G 3
 
  
 
and 5
 
  
 
AGG CTC
TAGG CTC AGT GAA GGC AG 3
 
 
 
. Screening by PCR was
performed using the primers, 5
 
  
 
AGC AGG AAG ATG GGC
ACA ATG ATG AAG 3
 
 
 
 and 5
 
  
 
TGG TAT CTA CTT CTG
CAA GCA GAA ATG 3
 
 
 
: a 250-bp product represented the mu-
tant allele and a 186-bp product corresponded to the wild-type
allele. The rate of homologous recombination was 1:35. Neomy-
cin primers 5
 
  
 
ATG ATT GAA CAA GAT GGA TTG CAC 3
 
 
 
and 5
 
  
 
TCG TCC AGA TCA TCC TGA TCG AC 3
 
 
 
 were
used to confirm neomycin gene deletion. Heterozygous Ig
 
 
 
c
 
→
 
 
 
c
 
mice were backcrossed to C57BL/6 for two generations after Cre
deletion before intercrossing. All mice were maintained under
specific pathogen-free conditions. All experiments shown were
performed with homozygous mice.
 
B Cell Purification and Western Blotting. 
 
B cells were purified
by negative selection from spleen using anti-CD43 magnetic mi-
crobeads (Miltenyi Biotec). For cross-linking experiments B cells
were resuspended at 10
 
8
 
/ml in RPMI with 1% FBS and were
cross-linked with 20 
 
 
 
g/ml goat anti–mouse IgM, 
 
 
 
 chain spe-
cific F(ab
 
 
 
)
 
2
 
 fragments (Jackson ImmunoResearch) for the indi-
cated times at 37
 
 
 
C. Cells were lysed in TX-100 buffer (50 mM
Tris, pH 7.5, 137 mM NaCl, 2 mM EDTA, 10% glycerol, 1%
Triton X-100, and inhibitors or 50 mM Tris/HCl, pH 7.7, 150
mM NaCl, 1% NP-40, 1 mM EDTA, 1 mM EGTA, 0.1% deoxy-
cholic acid, 10% glycerol, 1 mM PMSF, 0.2 mM Na
 
3
 
VO
 
4
 
, and
protease inhibitors) for Western blotting and in RIPA buffer (50
mM Tris/HCl, pH 7.7, 150 mM NaCl, 1% NP-40, 0.1% SDS,
0.1% deoxycholic acid, 1 mM PMSF, 0.2 mM Na
 
3
 
VO
 
4
 
, and pro-
tease inhibitors) for immunoprecipitation (IP). Lysates were incu-
bated for 15 min on ice and cellular debris were sedimented at
14,000 rpm for 15 min at 4
 
 
 
C. Lysates were resolved on
NuPAGE 4–12% Bis-Tris gels (Invitrogen) and immunoblotted
on Immobilon polyvinylidene fluoride membranes (Millipore).
For IP, cellular lysates were precleared with protein A–Sepharose
(Amersham Biosciences), incubated for 2 h with primary anti-
bodies, and captured with protein A–Sepharose. Visualization
was with protein A horse radish peroxidase (Amersham Bio-
sciences), donkey anti–rabbit IgG (Jackson ImmunoResearch
 
Laboratories) or goat and mouse IgG (Jackson ImmunoResearch
Laboratories) and Western Plus chemiluminescent reagent (NEN
Life Science Products). Antibodies used for IP and Western blot-
ting were anti-Ig
 
 
 
 and anti-Ig
 
 
 
 (38), 4G10 (Upstate Biotechnol-
ogy), anti-Syk (Santa Cruz Biotechnology, Inc.), and Phospho-
Syk (Cell Signaling Technologies).
 
Flow Cytometry.
 
 Single cell suspensions from bone marrow,
spleen, and peritoneal cavity were stained with FITC, PE, APC,
and biotin-conjugated mAbs visualized with Strepavidin red 613
(GIBCO BRL) or streptavidin PerCp (Becton Dickinson). mAbs
were anti-CD43, anti-IgM, anti-B220, anti-CD25, anti-IgD, anti-
CD19, anti-CD5, anti-CD21, anti-HSA, and anti-CD23 (BD
Biosciences). Data collection was performed on a FACSCalibur™
and analyzed using CellQuest™ software (Becton Dickinson).
 
In Vitro B Cell Cultures and Proliferation Assays. 
 
Purified
spleen B cells were cultured in RPMI 1640 (GIBCO-BRL) sup-
plemented with 10% FCS, 2 mM 
 
L
 
-glutamine (GIBCO-BRL),
100 IU/ml penicillin/streptomycin (GIBCO-BRL), and 100
 
 
 
M 2-mercaptoethanol (Sigma-Aldrich). Cells were stimulated
with CD40L at a concentration of 1:100 (CD8–gp39 fusion pro-
tein derived from insect cells; a gift from Dr. Randolph Noelle,
Dartmouth Medical School, Hanover, NH; reference 39), or 25
 
 
 
g/ml LPS (Sigma-Aldrich), or 10 
 
 
 
g/ml goat anti–mouse
F(ab
 
 
 
)
 
2
 
 IgM (Jackson ImmunoResearch), or 5 
 
 
 
g/ml RP105 (a
gift from A. Tarahkovsky, The Rockefeller University), and 1:2,000
CpG (MWG Biotech).
For thymidine incorporation assays 3 
 
 
 
 10
 
5
 
 cells were cultured
in triplicate for 48 h in 96-well flat bottom plates and pulsed with
1 
 
 
 
Ci/ml of [3H]thymidine for 6 h. For labeling with 5-carboxy-
fluorescein diacetate succinimidyl ester (CFDA,SE; Molecular
Probes) 107 cells were incubated at 37 C for 10 min in 1 ml
RPMI 1640 supplemented with 5  M CFDA,SE. Cultures were
stained with PE-CD19 (BD Biosciences) and analyzed on a
FACScalibur™ using CellQuest™ software.
BCR Internalization Assays.  Single cell suspensions were
equilibrated in ice water baths and stained with biotin-SP goat
anti–mouse IgM Fab’ fragment (  specific; Jackson ImmunoRe-
search). An aliquot of cells was fixed with PBS containing 0.5%
paraformaldehyde for the time 0 (T0) cell surface expression
value. The remaining cells were incubated at 37 C for the indi-
cated times (Tn). Reactions were terminated with ice-cold PBS
containing 0.5% paraformaldehyde and cells stained with PE-
B220 (BD Biosciences) and Streptavidin red 670 (GIBCO
BRL). Percent internalization was calculated by the formula %
sIgM(T0)   % sIgM(Tn)/% IgM(T0)   100.
Bromodeoxyuridine (BrdU) Labeling.  8–12-wk-old Ig c→ c
and age- and sex-matched control (B6/129F1) mice received
BrdU (Sigma-Aldrich) in their drinking water at a concentration
of 0.5 mg/ml. The number of B220  bone marrow and spleen
cells was not significantly altered during the 63-d time course.
Staining was with anti-BrdU mAb using the BrdU flow kit™
(BD Biosciences) and data was collected using a FACScalibur™
(Becton Dickinson). Fitted curves were drawn using Microsoft
Excel software. Approximate half-life was equal to time point
where 50% of cells stained positively for BrdU.
Ca2  Flux.  Spleen cell suspensions from C57BL/6 mice and
Ig c→ c mice were adjusted to 5   106/ml in PBS containing
1% FCS, 1 mM CaCl2, 1 mM MgCl2 (loading buffer), and incu-
bated with 1.5  M Indo-1-AM (Molecular Probes) for 30 min at
37 C. Cells were stained with PE–anti-B220 and Fab  FITC goat
anti–mouse IgM (Jackson ImmunoResearch Laboratories) to de-
termine gating. Calcium flux was measured by fluorescence emis-
sion ratios of Indo-1-AM on a dual laser FACSVantage™ (Bec-Reichlin et al. 857
ton Dickinson) at 395/510 nm on B220 IgM  cells. A baseline
reading was collected for 60 s before cross-linking the BCR with
30  g/ml goat anti–mouse IgM F(ab )2 fragments (Southern Bio-
technology Associates, Inc.).
Immunization.  6–8-wk-old Ig c→ c and B6/129F1 con-
trols were immunized intraperitoneally with either 50  g alum
precipitated 4-hydroxy-3-nitrophenylacetyl coupled to chicken
gamma globulin (NP-CGG; Biosearch Technologies) or 50  g
NP-Ficoll in PBS. Blood was collected from the tail vein of
each mouse before immunization and then again at days 7, 14,
21, and 31 postimmunization for the mice immunized with
NP-CGG and at days 7, 14, 21, and 28 post immunization for
the NP-Ficoll group. NP-specific IgM and IgG levels were
measured by ELISA using NP16BSA as a capture and developed
with goat anti-IgM or anti-IgG coupled to horse radish peroxi-
dase (Southern Biotechnology Associates, Inc.). Immunoabsor-
bance was read at 415 nm and titers were calculated relative to
control sera from un-immunized mice. Three mice were used
in each group.
Results
Ig c→ c Mice. To determine whether Ig  and Ig 
have unique or redundant functions in mature B cells we
replaced the cytoplasmic tail of Ig  with the cytoplasmic
tail of Ig  by gene targeting (Fig. 1 A, Ig c→ c). Ig c→ c
protein expression in B cells was confirmed by Western
blotting of purified B cell lysates using antibodies specific
for the cytoplasmic domains of Ig  and Ig  (38, 40). Con-
trol lysates showed the presence of both Ig  and Ig  (Fig. 1
B). In contrast, there was no wild-type Ig  in the lysates
from Ig c→ c B cells. Instead we found a new species re-
active with the anti-Ig  antibody that had the predicted
mobility of the Ig c→ c protein and no additional Ig 
species (Fig. 1 B). We conclude that B cells from Ig c→ c
mice do in fact express only the chimeric Ig  protein with
the cytoplasmic tail of Ig .
B Cell Development in Ig c→ c Mice.  To examine the
effects of the Ig  cytoplasmic tail on development of B lin-
eage cells we compared B cells from Ig c→ c mice (BCR
with two Ig  tails) with B cells from Ig  C mice (BCR
with a single Ig  tail; reference 35) and wild-type controls
(Ig -Ig ).
Like Ig  C, Ig c→ c mice showed an increase in
IgM B220lowCD43  pro-B cells, normal levels of IgM 
B220lowCD25  preB cells and a decrease in the number of
immature IgM B220lowIgD /low B cells. In addition, im-
mature Ig c→ c B cells displayed decreased surface IgM
and IgD expression (Figs. 1 C and 2 A). Lower IgM levels
were also found in Ig  C B cells but these cells were se-
verely impaired in B cell development (35). Ig c→ c dif-
fered from Ig  C in that BCRs with two Ig  tails sup-
Figure 1. Ig c→ c mice. (A)
Scheme for gene targeting depicts
the genomic Ig  locus (top),
targeting vector (middle), and
recombinant allele after neomycin
gene deletion (bottom). Exons
are represented by boxes (Ig 
cytoplasmic exons [black] and
Ig  cytoplasmic exons [cross-
hatched]), lox P sites by open
triangles, and the probe is shown
by a striped box. (B) Western
blot analysis. Wild-type (wt) and
Ig c→ c B cell lysates were
probed with antibodies specific
for the cytoplasmic domains of
Ig  and Ig . Numbers above the
lanes represent micrograms of
lysate per sample. Bands with the
expected relative mobility of Ig ,
Ig , and Ig c→ c proteins are
indicated to the left of the fig-
ure. (C) B cell development in
the bone marrow of wild-type,
Ig  C, and Ig c→ c mice.
Numbers represent the percent-
ages of lymphocytes except for the
plots depicting CD25 versus IgM
that were gated on B220  cells.
(D) Spleen B cells in wild-type,
Ig  C, and Ig c→ c mice.
Numbers represent the percent-
ages of lymphocytes. Rows 2
through 4 were pregated on the B220  population. Transitional 1 cells (T1) were HSA CD21 ,
transitional 2 cells (T2) were HSA CD21 , and mature (M) B cells were HSAloCD21 .
Peritoneal B cells were gated on lymphocytes as per forward versus side scatter parameters
and then fractionated into B1a (B220lo CD5 ), B1b (B220lo CD5 ), and B2 (B220hiCD5 ).Ig  Supports Development of Mature But Anergic B Cells 858
ported development of mature recirculating IgM B220high
B cells whereas a single Ig  tail in Ig  C mice did not
(Figs. 1 C and Fig. 2 A; reference 35), but the number of
mature recirculating IgM B220high B cells in the bone mar-
row in Ig c→ c was somewhat lower than wild-type con-
trols (12% Wt vs. 4% Ig c→ c; Figs. 1 C and Fig. 2 A).
The total number of cells in spleens of Ig c→ c mice was
similar to wild type (Table I). However, we found a 30%
overall decrease in B220 IgM  B cells with a small relative
increase in marginal zone B cells (Figs. 1 D and Fig. 2 B).
In the peritoneal cavity Ig c→ c mice showed a sevenfold
relative decrease in the number of B1a cells but normal
number of B1b and B2 cells (Fig. 1 D). Heterozygous
Ig c→ c mice were no different than wild-type controls in
B cell development or any of the signaling assays discussed
below. We conclude that BCRs with two Ig  tails support
development of all B cell subtypes except B1a cells.
Decreased Levels of Cell Surface BCR.  Mutation of the
Ig  ITAM (Ig FF/FFmice) increased the level of cell surface
BCR expression suggesting that phosphorylation of ITAM
tyrosines in the cytoplasmic tail of Ig  might regulate cell
surface BCR levels (41). Consistent with this idea B cells
with two cytoplasmic Ig  chains showed decreased levels
of cell surface BCR (Fig. 3 A). The decrease in surface
BCR expression on Ig c→ c B cells was not due to a
change in steady-state levels of Ig  mRNA or in Ig  pro-
tein synthesis as measured by RNase protection and
[35S]methionine metabolic labeling experiments (unpub-
lished data). However, the decreased surface BCR level
was associated with increased BCR internalization as mea-
sured with a biotinylated Fab’ anti-IgM (Fig. 3 B).
Ig c→ c B cells showed increased and more rapid receptor
internalization than wild-type controls. We conclude that
lower levels of cell surface BCR in Ig c→ c mice are asso-
ciated with increased BCR internalization.
To determine whether decreased cell surface BCR ex-
pression in Ig c→ c mice is the result of BCR signaling
we bred Ig c→ c and Ig FF/FF mice (Ig c→ c/Ig FF/FF
mice; reference 41). Ig c→ c/Ig FF/FF B cells differ from
Ig c→ c B cells in that only one of the two cytoplasmic
Ig  tails in Ig c→ c/Ig FF/FF B cells carries a functional
ITAM. We found that B cells with two functional Ig 
ITAMs (Ig c→ c) had the lowest BCR levels, those with
no functional Ig  ITAMs (Ig FF/FF) had the highest levels
and B cells with one functional Ig  ITAM (Ig c→ c/
Ig FF/FF) were intermediate (Fig. 3 A). We conclude that
an active feedback signaling mechanism mediated by tyro-
sine phosphorylation of the Ig  cytoplasmic domain is re-
sponsible for the low levels of BCR on Ig c→ c B cells.
Half-Life of Ig c→ c B Cells In Vivo.  Ig c→ c mice
displayed a small decrease in the numbers of mature B cells
in spleen and a more significant decrease in immature B
cells in the bone marrow (Fig. 2 B). B cell half-life is influ-
enced by the rate of B cell influx and is increased in the ab-
sence of bone marrow B cell production (42). To deter-
mine the life span of Ig c→ c B cells we performed
continuous labeling experiments using BrdU. In these ex-
periments the half-life of cells in any compartment is the
time taken to label 50% of the population. We found an in-
crease in the half-life of Ig c→ c B cells in spleen (Fig. 4
A, 58.3 d vs. 23.4 d for the wild type). We conclude that
Ig c→ c B cells have a significant defect in passing early B
cell checkpoints in the bone marrow but once established
in the periphery these cells have a longer life span than
wild-type B cells.
Figure 2. B cells in bone marrow and spleen in wild-type and Ig c→ c
mice. Numbers show percentages of bone marrow or splenic lympho-
cytes. (A) Bone marrow. Pro B cells were CD43 B220 , pre BII cells
were CD25 IgM , immature B cells were IgM IgDlo, and mature B cells
were IgM IgDhi. (B) Spleen. T1, T2, and mature B cells were defined as
in Fig. 1. Marginal zone B cells were CD21 CD23  and follicular B cells
were CD21 CD23 . Filled diamonds represent wild-type and open
squares represent Ig c→ c mice. Each symbol shows an individual mouse.
Bars represent the means of all mice in a group.
Table I. Total Numbers of Nucleated Cells in Bone Marrow and 
Spleens of 8–12-wk-old Ig c→ c Mice and Wild-type Controls
Bone marrow (n = 9) Spleen (n = 17) 
Wild type 27.4   106  SD   6.80 71.5   106  SD   21.6
Ig c→ c 24.2    106  SD   7.26 61.5   106  SD   19.9
n, number of mice tested.Reichlin et al. 859
Ig c→ c B Cells Are Relatively Unresponsive to T Cell–
dependent and –independent Antigens In Vivo.  To determine
whether Ig c→ c B cells respond to antigen in vivo we
immunized mice with nitrophenol-28 coupled to NP-
CGG, a T cell–dependent antigen or nitrophenol-59 cou-
pled to ficoll (NP-Ficoll) a T cell–independent antigen.
Ig c→ c mice showed a three- to fivefold reduction in
specific IgM and IgG responses to T-dependent antigens
when compared with wild-type controls and they were
unable to respond to NP-Ficoll (Fig. 5). We conclude that
despite their longevity Ig c→ c B cells are relatively aner-
gic to stimulation with antigen in vivo.
Figure 3. Cell surface BCR
expression. (A) IgM and IgD
surface expression on B cells
from bone marrow and spleen of
wild-type, Ig c→ c, Ig c→ c/
Ig FF/FF, and Ig FF/FF mice.
Splenic B cells were purified by
negative selection before staining.
(B) IgM internalization assessed
by flow cytometry. Percent in-
ternalization was calculated by the
formula % sIgM(T0)    %
sIgM(Tn)/% IgM(T0)    100.
The graph shows three separate
experiments. Wild type (filled
diamonds) and Ig c→ c (filled
squares).
Figure 4. (A) B cell lifespan in bone marrow and
spleen in wild-type and Ig c→ c mice measured by
BrdU. Diamonds show wild-type B cells and circles
show the Ig c→ c B cells. Immature B cells (bone
marrow) and mature B cells (spleen) were defined as in
previous figures. Half-life was the time when 50% of
the cells were BrdU labeled. Immature B cells were as
in previous figures. Spleen immature B cells were
IgM IgDlo, mature B cells were IgMloIgDhi, and T
cells were CD3 .Ig  Supports Development of Mature But Anergic B Cells 860
Proliferation Responses In Vitro.  To determine whether
the inability to respond to antigen reflects a B cell autono-
mous defect we stimulated Ig c→ c B cells with mitogens
in vitro. Purified B cells were labeled with CFDA,SE and
stimulated with anti-IgM, CD40L, RP105, CpG, or LPS
(Fig. 6, A and E). Ig c→ c B cells responded to anti-IgM
stimulation by up-regulating CD69 and CD86 expression
(Fig. 6 B). However, Ig c→ c B cells failed to proliferate in
response to BCR cross-linking. Only a small number of the
B cells stimulated with anti-IgM diluted CFSE; thymidine
incorporation was also severely decreased compared with the
wild-type control (Fig. 6, A and C). To determine whether
the lack of responsiveness to BCR stimulation was due to a
signaling defect as opposed to a problem with receptor as-
sembly we measured responses to anti-IgM by Ig c→ c/
Ig FF/FF B cells, which carry ITAM tyrosine mutations in
one of the two Ig  tails. We found that mutating the ITAM
tyrosines in Ig  partially rescued the unresponsive phenotype
in Ig c→ c/Ig FF/FF B cells (Fig. 6 A). Whereas Ig c→ c B
cells fail to proliferate in response to anti-IgM treatment,
Ig c→ c/Ig FF/FF B cells divided, although the average
number of divisions was somewhat lower than wild-type or
Ig FF/FF B cells (Fig. 6 A). Thus, the lack of responsiveness
found in Ig c→ c B cells is at least in part due to a process
that requires Ig  ITAM tyrosine phosphorylation.
Ig c→ c showed normal levels of cell surface CD40L
and RP105, but diminished responses to CD40L, RP105,
CpG, and LPS stimulation (Fig. 6, C–E). There was less
cell division, as measured by CFSE dye dilution, in re-
sponse to CD40L and RP105, and fewer cells were in-
duced to divide by LPS or CpG (Fig. 6 E). These results
were confirmed by measuring [3H]thymidine uptake in re-
sponse to the same stimuli (Fig. 6 C). These differences
were not due to a change in the number of cells undergo-
ing apoptosis (Fig. 6; and unpublished data). We conclude
that Ig c→ c B cells show modestly decreased responses to
a broad range of mitogenic stimuli in vitro.
To determine whether proximal receptor signaling is de-
creased in Ig c→ c B cells we measured Ca2  flux responses
to BCR cross-linking. We found that Ig c→ c B cells
showed impaired Ca2  responses compared with wild-type
controls (Fig. 6 F). To further characterize the proximal
BCR signaling in Ig c→ c mice we examined total phos-
phorylation, as well as Ig  and Syk phosphorylation after
BCR cross-linking (12–18). We found an overall decrease in
total phosphorylation consistent with the lower levels of
Ca2  signaling in Ig c→ c B cells (Fig. 7 A). In addition,
Ig c→ c B cells showed little Ig  phosphorylation in re-
sponse to BCR cross-linking (Fig. 7 B). Finally, phosphory-
lation of Syk was substantially reduced in Ig c→ c mice
when compared with wild-type controls (Fig. 7 C). We con-
clude that decreased surface BCR levels on Ig c→ c B cells
are associated with decreased intensity of proximal signaling.
Discussion
Our experiments extend previous work by examining
the function of Ig  and Ig  in mature B cells in vivo. We
show that a BCR containing a signaling module composed
of a homodimer of Ig  cytoplasmic tails can support the
development of all currently defined subgroups of B cells
with the exception of B1a cells and therefore Ig  and Ig 
are redundant for all stages of B cell development. In con-
trast, Ig  and Ig  have distinct functions in regulating
BCR surface expression and setting thresholds for mature B
cell activation.
Figure 5. Antibody responses in Ig c→ c mice.
Graphs show anti-NP IgM and IgG responses measured
by ELISA on days 7, 14, 21, and 28 (for NP-CGG) and
days 7, 14, 21, and 31 for (NP-Ficoll) after immunization
with T-dependent (NP-CGG) or -independent (NP-
Ficoll) antigens. The filled diamonds and the open
squares represent serum titers in individual wild-type
and Ig c→ c mice, respectively. The ordinate shows
OD 415 nm relative to nonimmunized controls. The
line shows the means for each group at a given time
point. There were three mice in each group.Reichlin et al. 861
Ig  and Ig  and B Cell Development. Early B cell devel-
opment requires preBCR signaling and either Ig  or Ig 
cytoplasmic domains are sufficient to satisfy this require-
ment (32, 33). Signaling through BCR ITAM tyrosines
was required for early B cell development but the BCR
ITAMs were redundant and a single functional Ig  ITAM
was sufficient to reconstitute development (32, 33, 41, 43).
Transgenic Fc chimeras fused to the cytoplasmic tails of Ig 
or Ig  differed from Ig  chimeras in that they appeared to
support mature B cell development, but the distribution of
different B cell subpopulations was not examined and the
Fc chimeras were not antigen receptors so B cell function
could not be studied (32, 33).
Gene targeting confirmed the transgenic experiments
and showed that BCRs lacking either the cytoplasmic do-
main of Ig  or Ig  (Ig  C and Ig  C) were sufficient for
B cells to progress to the immature stage of development
but not the mature B cell stage (34, 35). Ig  C and Ig  C
differed in that Ig  C progressed to the immature stage of
development nearly normally whereas Ig  C B cells
showed a partial block in the transition between preB and
immature stage of development (34, 35). These findings
Figure 6. In vitro responses
to mitogens. (A) Histograms
show CFSE staining on wild-
type, Ig c→ c, Ig FF/FF, and
Ig c→ c/Ig FF/FF CD19  cells
cultured with Fab 2 anti-IgM. The
dark line represents cells at time 0
with no stimulation, the light line
represents number of cell divisions
after 72 h in culture. (B) Up-
regulation of activation markers in
wild-type and Ig c→ c B cells.
Cell surface expression of CD69
and CD86 after 24 h incubation
with 10 mg/ml goat anti–mouse
(Fab )2 fragments or CD40L.
Solid peaks show unstimulated
cells and open peaks represent expression after stimulation. (C) [3H]Thymidine incorporation
by wild-type (black bars) and Ig c→ c (hatched bars) B cells after a 54-h culture. Error bars
show means on triplicate cultures in an experiment representative of three independent ex-
periments. (D) Histograms show surface expression of CD40 and RP105 by wild-type (or-
ange) and Ig c→ c (green) B cells. (E) Histograms show CFSE dilution by wild-type (or-
ange) and Ig c→ c (green) CD19  cells stimulated with CD40L, or CpG, or LPS, or
RP105 after a 72-h culture. (F) Ca2  flux response to BCR cross-linking in splenic B cells
in wild-type and Ig c→ c mice. Contour plots represent Ca2  flux of splenic B cells mea-
sured by the fluorescence 395:510 nm ratio of Indo-1-AM emission accumulated over
1,024 s. Splenic B cells were gated by anti-B220 and anti-Fab  IgM staining. Baseline fluo-
rescence was acquired for 60 s before cross-linking with goat anti–mouse IgM (Fab )2 at a
final concentration of 30  g/ml.
Figure 7. Protein tyrosine
phosphorylation. Purified B cells
were stimulated with 10  g/ml
goat anti–mouse F(ab) 2 for the
indicated times. (A) Tyrosine
phosphorylation of total cellular
proteins (5   106 cells/lane)
detected by antiphosphotyrosine
immunoblotting with the mAb
4G10. (B) Tyrosine phosphory-
lation in Ig  immunoprecipitates.
Ig  immunoprecipitates were im-
munoblotted with mAb 4G10
to detect tyrosine phosphoryla-
tion. The lower panel shows the
same blot stripped and reprobed
with Ig  antibody. (C) Syk tyro-
sine  phosphorylation. Anti-Syk
immunoprecipitates were immu-
noblotted with mAb 4G10 to
detect tyrosine phosphorylation.
The lower panel shows the
same blot stripped and reprobed
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were reminiscent of the observation that thymocyte devel-
opment is dependent on the number of T cell receptor  
ITAMs (44–46). Single ITAM-containing BCRs in Ig  C
and Ig  C mice were simply not sufficient for complete B
cell maturation (34, 35).
In vitro experiments with isolated Ig  and Ig  cytoplas-
mic domains suggested that the two transducers bind to dif-
ferent but overlapping sets of kinases (16). However, trans-
fection experiments with chimeric receptors and transgenic
experiments failed to show qualitative differences in early B
cell development or signaling stimulated by Ig  or Ig  (6, 7,
9, 11, 28–35). Mature B cells are therefore unique in their
requirement for both Ig  and Ig  for normal levels of BCR
expression and physiologic responses to BCR cross-linking.
As both Ig  and Ig  have a single ITAM, the physio-
logic differences in mature B cell signaling could be due to
the non-ITAM residues. Among the non-ITAM residues
in Ig  implicated in signaling are two non-ITAM tyro-
sines, 176 and 204, that bind the adaptor molecule BLNK
(20, 21, 26, 47, 48), which links the BCR with phospholi-
pase C , Vav, Grb2, Syk, Btk, and HPK1 (20, 25–27).
Mice that are BLNK deficient show a block in early B cell
development, decreased numbers of peripheral B cells, and
defective B cell activation (20, 21, 25, 27, 49–53). BLNK-
deficient mice also show an accumulation of mature B cells
whose phenotype is IgMhighIgDlow and increased expression
of surface preBCR (54, 55). These features would lend cre-
dence to the idea that BCRs with two Ig  cytoplasmic do-
mains in Ig c→ c B cells may simply recruit abnormally
high levels of BLNK and its signaling partners, however,
we find lower levels of BLNK phosphorylation in Ig c→ c
B cells (unpublished data) and therefore the two non-
ITAM tyrosines in Ig  that recruit BLNK are not likely to
be responsible for the difference in signaling by Ig  and
Ig  in mature B cells in vivo.
Ig c→ c mice show a small relative enlargement of the
MZ compartment but a near absence of B1 cells. Several
signaling molecules have been shown to be essential for
normal MZ B cell development including CD19, btk,
pyk2, NF- B, aiolos, DOCK2, and Lsc (56–61). In addi-
tion, Kraus et al. showed that impaired Ig  signaling in a
BCR with point mutations of the Ig  ITAM tyrosines re-
sults in decreased MZ B cells production (41). Together
our data suggests that the size of the MZ compartment is
directly related to the number of Ig  ITAM tyrosines.
Similarly B1 development is BCR dependent and re-
quires positive selection by low affinity interaction with
self-antigen (62–64) The reduced cell surface BCR and de-
creased signaling by Ig c→ c B cells may simply be insuffi-
cient for normal B1 selection. Alternatively, there may be a
specific requirement for Ig  signaling in the development
of the B1 population but this seems unlikely as Ig  is not
sufficient to produce B1 cells in Ig FF/FF mice.
Decreased Surface BCR Expression in Ig c→ c Mice.
Cell surface expression of mIg requires coexpression of ei-
ther Ig –Ig  or Ig  (6, 38, 65). This requirement is linked
to the presence of polar residues in the transmembrane do-
main of mIg that interact with Ig –Ig  (6). Once on the
cell surface the BCR is constitutively recycled from the
plasma membrane to endosomes where captured antigens
are processed for presentation to cognate T cells. Signaling
by the cytoplasmic domains of Ig  and Ig  is essential for
BCR internalization and targeting to MHC II–containing
endosomes (47, 66). The idea that tyrosines in the cytoplas-
mic domains of Ig  and Ig  may be critical for constitutive
BCR internalization derived from studies of endocytosis of
the transferrin and LDL receptors (67, 68). Bulky hydro-
phobic amino acids such as phenylalanine or tyrosine in the
cytoplasmic domains of those receptors were required for
constitutive endocyotsis. Consistent with the role of such
residues in endocytosis Ig  tyrosines were found to be es-
sential for both signal transduction and antigen presentation
in cells lines transfected with Fc–Ig  chimeras (69). In con-
trast Ig  tyrosine residues were dispensable for internaliza-
tion (70). In addition, experiments with PDGFR chimeras
that contained both Ig  and Ig  showed that both cyto-
plasmic domains were required to regulate ligand-induced
internalization (47). The implication of these in vitro stud-
ies was that Ig  and Ig  had distinct but complementary
roles in mediating BCR internalization.
A role for Ig  in regulating BCR surface expression in
mature B cells in vivo was confirmed by gene targeting
(41). B cells with Ig  ITAM tyrosines mutated to phe-
nylalanine displayed increased surface BCR expression in
vivo (41). Although the mechanism for increased receptor
expression in Ig FF/FF mice was not determined three alter-
natives were suggested. First, B cells with increased levels
of surface BCR might be selected during development to
compensate for the decreased signaling activity of the mu-
tant BCR (41). Second, Ig  signaling might normally in-
hibit Ig  function (36, 71). In this scheme uninhibited Ig 
signaling would account for increased BCR surface expres-
sion in Ig FF/FF B cells and increased BCR signaling in Ig-
  C B cells (36, 71). However, Ig  C mutant B cells that
lack the Ig  cytoplasmic tail showed the same hyper-reac-
tive phenotype as Ig  C B cells (35). Thus, the negative
regulatory effect is not specific for either Ig  or Ig  and is
more likely due to inability of the single chain BCRs in
Ig  C and Ig  C B cells to recruit negative regulators of
BCR function such as Src homology 2 domain–containing
phophatase 1 (35). Finally, Ig  signaling might directly
control BCR surface expression or internalization (41). Ac-
cording to this hypothesis signals emanating from the Ig 
ITAM would be required to set cell surface BCR levels
and the absence of such signals in Ig FF/FF B cells would
lead to increased expression and a proportional increase in
BCR signaling. Our data is most consistent with the idea
that Ig  functions as such a regulator as we find lower sur-
face BCR levels when the BCR contains an additional Ig 
cytoplasmic domain. This decrease in BCR expression is
directly correlated with, and may be responsible for, the
decreased signaling by BCRs with two Ig  ITAMs. Fur-
thermore, phosphorylation of ITAM tyrosines is critical for
regulating surface BCR levels because Ig c→ c/Ig FF/FF
BCRs with a lower total number of active Ig  ITAMs
have increased BCR surface expression. Active feedbackReichlin et al. 863
regulation of cell surface receptor levels is a common
mechanism for regulating cellular sensitivity to persistent
stimuli. We speculate that Ig  performs this feedback func-
tion for regulating BCR surface expression in vivo.
Ig c→ c Mature B Cells Are Anergic.  Subthreshold sig-
naling leads to anergy in both T cells and B cells, possibly by
partial stimulation of Ca2 -dependent pathways (72, 73). B
cells stimulated with submitogenic doses of anti-BCR anti-
bodies in vitro showed decreased surface BCR expression
and became relatively anergic to further stimulation (74,
75). In the same way, anti-hen egg lysozyme–specific B cells
became anergic when exposed to cognate antigen in vivo,
and this was accompanied by decreased BCR surface ex-
pression (76). Finally, similar effects including decreased sur-
face BCR expression and inability to secrete antibody were
found in anti-double– (77) and anti-single–stranded DNA
Ig transgenic mice (78). In Ig-transgenic models, sub-
threshold BCR signaling was associated with increased
baseline Ca2  levels (73,79), PKC -dependent changes in
Ca2  responses, and nuclear signaling pathways including
NF B and JNK (79–82). In contrast, we found no differ-
ences in resting Ca2  levels in Ig c→ c B cells. Anergy in
this case may be due to an overall decrease in signaling as a
result of low levels of cell surface receptor expression.
Ig c→ c B cells spontaneously display many of the fea-
tures of anergic B cells, including decreased surface BCR
expression and diminished responses to BCR cross-linking.
In addition Ig c→ c B cells showed impaired polyclonal
responses to T cell–independent and –dependent antigens
in vivo. These changes in sensitivity to BCR cross-linking
required signal transduction and Ig  tyrosine phosphoryla-
tion because they were partially reversed in Ig c→ c/Ig FF/FF
B cells in which one of the two BCR ITAMs is inacti-
vated. The major difference between Ig c→ c B cells and
other anergic B cells is that they are long lived when com-
pared with wild-type B cells (77, 83). Little is known about
how B cell longevity is regulated but our experiments sug-
gest that Ig  may play an important role in this process.
We conclude that Ig  and Ig  signaling have distinct roles
in regulating mature B cell physiology in vivo.
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